Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 4447-4458

  Roohi, Farnoosh ^a   Lohrke, Jessica ^a   Ide, Andreas ^a   Schütz, Gunnar ^a   Dassler, Katrin ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Blood half life; MRI; Relaxivity; SPIO

Indexed keywords

IRON; MACROGOL; POLYACRYLIC ACID; STARCH; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTROLLED STUDY; HALF LIFE TIME; INFRARED SPECTROSCOPY; IONIC STRENGTH; IRON TRANSPORT; LIGHT SCATTERING; MACROPHAGE; MATERIAL COATING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHAGOCYTOSIS; REACTION TIME; RELAXATION TIME; TEMPERATURE SENSITIVITY; TRANSMISSION ELECTRON MICROSCOPY;

ACRYLIC RESINS; ANIMALS; CELL LINE; CONTRAST MEDIA; HALF-LIFE; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE; OXIDES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; STARCH; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

RATTUS;

EID: 84870352504     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S33120     Document Type: Article

References (23)

1. Chen B, Wu W, Wang X. Magnetic iron oxide nanoparticles for tumor-targeted therapy. Curr Cancer Drug Targets. 2011;11(2):184-189.
2. Laurent S, Dutz S, Hafeli UO, Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011;166(1-2):8-23.
3. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 1990;175(2):489-493.
4. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006;34(1):23-38.
5. Almeida JP, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011;6(5):815-835.
6. Simberg D, Park JH, Karmali PP, etal. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials. 2009;30(23-24):3926-3933.
7. Geng Y, Dalhaimer P, Cai S, etal. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol. 2007;2(4):249-255.
8. Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul. 1996;13(3):245-255.
9. Cole AJ, David AE, Wang J, Galban CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32(8):2183-2193.
10. Simon GH, von Vopelius-Feldt J, Fu Y, etal. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Invest Radiol. 2006;41(1):45-51.
11. Lohrke J, Briel A, Mäder K. Characterization of superparamagnetic iron oxide nanoparticles by asymmetrical flow-field-flow-fractionation. Nanomedicine. 2008;3(4):437-452.
12. Hasegawa M, Hokkoku S, Inventors; Meito Sangyo Kabushiki Kaisha (Nagoya, JP), assignee. Magnetic iron oxide-dextran complex and process for its production US patent 4101435. Jun 14, 1976.
13. Saywell L, Cunningham B. Determination of iron: colorimetric o-phenanthroline method. Industrial and Engineering Chemistry Analytical Edition. 1937;9(2):67-69.
14. Miguel OB, Gossuin Y, Morales MP, Gillis P, Muller RN, Veintemillas-Verdaguer S. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles. Magn Reson Imaging. 2007;25(10):1437-1441.
15. Cullity BD, Graham CD. Introduction to magnetic materials. Philadelphia, PA: Wiley-IEEE Press; 2009.
16. Poselt E, Kloust H, Tromsdorf U, etal. Relaxivity optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T(2)-weighted spin-echo imaging. ACS Nano. 2012;6(2):1619-1624.
17. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40(11):715-724.
18. Larsen EK, Nielsen T, Wittenborn T, etal. Size-dependent accumulation of PEGylated silane-coated magnetic iron oxide nanoparticles in murine tumors. ACS Nano. 2009;3(7):1947-1951.
19. Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials. 1988;9(4):356-362.
20. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 2009;9(5):1909-1915.
21. Platt N, Gordon S. Scavenger receptors: diverse activities and promiscuous binding of polyanionic ligands. Chem Biol. 1998;5(8): R193-R203.
22. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol. 2005;23(11):1418-1423.
23. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23(7):1553-1561.